Brown adipose tissue mitochondria express the unique thermogenic uncoupling protein-1. Recently, brown adipocyte progenitors have been identified in the CD34 þ cell population of human skeletal muscle. The aims of this study were firstly to determine if obesity and diabetes have altered amounts of muscle brown adipocyte progenitors and, secondly, to establish if the latter are correlated with clinical parameters of obesity and diabetes. Body mass index (BMI), plasma glucose, insulin, cholesterol and triglycerides as well as homeostasis model assessment were measured in lean (n ¼ 10), obese (n ¼ 18) and obese-diabetic (n ¼ 15) subjects and muscle biopsies were taken from the rectus abdominus. CD34 being also expressed on endothelial cells, we measured CD31, another endothelial marker, and expressed the brown adipocyte progenitors, as the CD34/CD31 mRNA ratio. The latter was significantly reduced in the obese vs lean subjects suggesting a smaller pool of brown adipocyte progenitors. More strinkingly, for lean and obese subjects negative correlations were observed between the CD34/CD31 mRNA ratios and BMI, fasting insulin levels and homeostasis model assessment. These correlations highlight the potential physiological relevance of the muscle CD34/CD31 mRNA ratio.
Introduction
Brown adipose tissue (BAT) in rodents is the main effector of adaptive thermogenesis due to its unique expression of the mitochondrial uncoupling protein-1 (UCP1). The latter acts as an uncoupler of oxidative phosphorylation and dissipates energy as heat. Recently, paracervical and supraclavicular metabolically active depots of BAT were identified in adult humans using 18 F-fluorodeoxyglucose positron emission tomography. [1] [2] [3] [4] [5] [6] It was observed that, in response to coldexposure, the 18 F-fluorodeoxyglucose uptake increased as did the volume and/or the prevalence of these BAT depots. [2] [3] [4] [5] 7 Additionally, the latter were decreased in obese subjects, 2 were positively correlated with resting metabolic rate, 2 and were negatively correlated with body mass index (BMI). 3 These correlations suggest that human BAT might have a role in adaptive thermogenesis and thus protect from the development of obesity.
From human skeletal muscle, we isolated CD34 positive (CD34 þ ) cells, which could differentiate in vitro into genuine brown adipocytes demonstrating high UCP1 levels and uncoupled respiration. 8 We also reported the existence of low levels of UCP1 mRNA in human muscle biopsies suggesting the presence of mature brown adipocytes in adult skeletal muscle. 8 As transgenic expression of UCP1 in muscle is known to increase insulin-mediated glucose uptake, 9 human skeletal muscle brown adipocytes might protect not only from obesity but also from insulin resistance. Presently, the mechanisms controlling the appearance of brown adipocytes in skeletal muscle are unknown. However, it is not unreasonable to expect that the availability and activation of CD34 þ brown adipocyte progenitors are involved and that the population of muscle brown adipocyte progenitors may be perturbed under metabolically challenged conditions as seen in obese and obese diabetic patients.
CD34 is also a surface marker of endothelial cells. 10 The skeletal muscle CD34 þ progenitors of brown adipocytes may either be endothelial cells or belong to another population. In this study, CD34 mRNA values were expressed as a ratio of CD31, another endothelial surface marker, 11 in an attempt to identify the cell population to which the brown adipocyte progenitors belong and, if they are not endothelial cells, to reduce the confounding influence of changes in vascularisation, which can occur in obesity. 12 The aims of this study were first, to measure and compare UCP1 mRNA level and the CD34/CD31 mRNA ratios, in muscle biopsy samples from lean, obese and obese-type 2 diabetic subjects, and second, to determine if these ratios correlated with clinical parameters of obesity and diabetes.
Subjects and methods

Subjects
Ten lean controls (4 men, 6 women; average age: 45.3±2.8), 18 obese (3 men, 15 women; average age: 36 ± 2.1) and 15 obese type-2 diabetic (9 men, 6 women; average age: 49.3±1.4) individuals participated in this study. Obese and obese type-2 diabetic patients were undergoing laparoscopically performed adjustable gastric banding surgery, as previously described. 13 None of the patients were under thiazolidinedione but five of them were under insulin treatment. Lean patients were undergoing general abdominal surgical procedures unrelated to obesity or type-2 diabetes. Written informed consent was obtained from all subjects. This study was approved by the Deakin University Human Ethics Research Committee, The Avenue Hospital and Cabrini Hospital. Muscle samples (about 200 mg) were obtained from the rectus abdominus in the fasted state (8-18 h). All participants were under general anaesthesia, predominantly via short-acting propofol and maintained by a fentanyl, rocuronium and volatile anaesthesia mixture. Following collection, which was performed 30 min after the beginning of the operation, surgical samples were immediately frozen in liquid nitrogen.
Reverse transcription and real-time PCR
Quantitative real-time PCR was performed as previously described. 8 Cyclophilin A was used as a control to account for any variations due to the efficiency of the reverse transcription. The upstream and downstream oligonucleotide primers were chosen on both sides of an intron to prevent amplification of contaminating genomic DNA. The primers used were as follows: UCP1 
Statistical analysis
Statistical analysis was performed using SPSS version 15.0 (SPSS Inc., Chicago, IL, USA). A one-way analysis of variance followed by LSD or Dunnett's T3 post-hoc test was used (where equal variances were not assumed) to determine the significance of differences between groups. Significance was set at Po0.05.
Results and discussion
The clinical profile of the participants of this study is presented in Table 1 . By definition, the body weight and BMI were higher in the obese and obese-diabetic patients than in the lean group. The BMI values of the obese patients were in the range of massive obesity. Fasting plasma glucose was increased in the obese-diabetic group whereas fasting plasma insulin was increased in the obese and even more in the obese-diabetic group as compared with the lean group. The same was true for the homeostasis model assessment, which provides an estimate of insulin resistance. The obesediabetic group therefore met the criteria of type-2 diabetes. The obese-diabetic group was also hypertriglyceridemic, but not hypercholesterolemic.
UCP1 mRNA was measured by quantitative reverse transcriptase PCR in skeletal muscle biopsies from lean, obese and obese-diabetic subjects. As shown in Figure 1a , UCP1 mRNA expression was increased threefold (Po0.05) in the muscle of the obese as compared with that of the lean group. Although a similar tendency was observed in the obese-diabetic group, it did not reach statistical significance. Furthermore, when lean, obese and obese diabetic subject samples were analysed simultaneously a positive correlation was observed between UCP1 mRNA levels and BMI (inset Figure 1a) . On the contrary, in humans, the activity of whole body BAT was found to be negatively correlated with BMI. 2 These opposite regulations might underline metabolic differences between muscle and BAT brown adipocyte Human muscle brown adipocytes progenitors AP Russell et al populations. It can be hypothesised that the increase in skeletal muscle UCP1 expression observed in our study is a consequence and not a cause of obesity. The tissue topography and fate of CD34 þ cells was recently studied. Immunohistochemical analysis of small vessels in various organs showed, in addition to endothelial cells co-expressing CD34 and CD31, adventitial cells, expressing CD34 alone. The adventitial CD34 þ CD31À cells of fetal and adult organs yielded in vitro a progeny of cells exhibiting the features of multipotent mesenchymal stem cells. 14 In consideration of this, we postulated that the brown adipocyte progenitors were CD34 þ CD31À cells. The CD34/ CD31 mRNA ratio would therefore be a potential marker of skeletal muscle brown adipocyte progenitor cells and its value would be independent of changes in vascular/ endothelial cells. The CD34/CD31 mRNA ratio was decreased by 65% (Po0.05) and 52%, (P ¼ 0.08) respectively, in the obese and obese diabetic subjects, as compared with the lean group (Figure 1b) . This observation suggests, in obese subjects, a relative reduction in the number of adventitial cells in the skeletal muscle vascular walls that might be due to exhaustion or to a limited capacity of recruitment of these cells. CD31 is also expressed on the surface of the monocytes/macrophages. 11 To investigate the possible contribution of changes in the muscle macrophages in the observed fluctuations of CD31 we also measured in the same samples the expression of CD68, which is a marker of the macrophages absent from the endothelial cells. 15 The levels of CD68 were identical in lean, obese and obesediabetic patients (not shown), suggesting that possible fluctuations of CD31 are unlikely to be ascribed to changes in the level of macrophages. When lean and obese patients were analysed simultaneously, negative correlations were observed between CD34/ CD31 mRNA ratios and three parameters known to be increased in obesity and type-2 diabetes, including BMI (r ¼ À0.52; P ¼ 0.005), fasting insulin level (r ¼ À0.44; P ¼ 0.002) and homeostasis model assessment (r ¼ À0.54; P ¼ 0.003) (Figure 1c) . No correlations were observed between the amounts of CD34 or CD31 mRNA, normalised using the corresponding Cyclo A values, and the parameters listed in Table 1 . The fact that only the CD34/CD31 mRNA ratios were correlated with biological parameters highlights the potential physiological relevance of this ratio. Our observations suggest that the CD34/CD31 ratio may provide a marker for human skeletal muscle brown adipocyte progenitors belonging to the subpopulation of CD34 þ CD31À adventitial mesenchymal stem cells described by Corselli et al. 14 However, at present, our observations remain indirect. Future studies should attempt Table 1 and (b) were used. Human muscle brown adipocytes progenitors AP Russell et al to confirm the findings using flow cytometry with larger amounts of human tissue or attempt to draw conclusions from animal models of human obesity and diabetes. It is noteworthy that no correlation was observed between the CD34/CD31 ratio and the amount of skeletal muscle UCP1 mRNA (not shown), suggesting an absence of cross-talk between non-differentiated and differentiated cells. Altogether, the observations of this study, based on the mRNA expression of surface markers, suggest that a population of adventitial cells, possibly representing brown adipocyte progenitors, may exist in human skeletal muscle that is interconnected with obesity and insulin resistance. Future studies should aim to establish the precise role of these cells and their potential as targets to fight not only obesity but also insulin resistance.
